Promote the Progress� ::: J. Matthew Buchanan's Patent Blog ::: Brazil is so trendy...its pharma patent-busting technique is starting to catch on: "In the fall of 2005, Brazil successfully used the TRIPs compulsory licensing provisions as a sword to negotiate lower prices on patent-protected drugs from big pharma. Abbott flinched when faced with this novel approach, and agreed to drastic discounts to avoid an 'official' compulsory license.
Back then, I viewed the agressive actions of the Brazilian government as 'a beginning' of a new trend..."
